NCT00894374View on ClinicalTrials.gov

Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Falciparum Malaria
Interventions
DRUG

Artesunate (Test)

Oral tablet, single dose, 1 x 100 mg

DRUG

Artesunate (Comparator)

Oral tablet, single dose, 2 x 50 mg

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY